Erlotinib Temporarily Not Available Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC)

IndicationsStatusPurposePhase
Temporarily Not AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01297101Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy